Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 43.75
+0.83 (1.93%)
Apr 24, 2025, 2:45 PM CST
SHE:002653 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 395.46 | 295.11 | 277.07 | 345.06 | 636.62 | Upgrade
|
| Depreciation & Amortization | 245.54 | 219.58 | 184.12 | 153.19 | 104.59 | Upgrade
|
| Other Amortization | 9.15 | 2.91 | 4.29 | 3.1 | 2.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | -31.1 | 0.28 | 0 | 0.13 | -0.33 | Upgrade
|
| Asset Writedown & Restructuring Costs | 83.19 | 13.02 | 0.84 | 0.62 | 18.79 | Upgrade
|
| Loss (Gain) From Sale of Investments | -117.39 | 60.47 | -227.72 | -420.77 | -296.17 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.79 | 0.3 | 0.91 | 0.32 | -0.24 | Upgrade
|
| Other Operating Activities | 109.61 | 42.13 | 167.43 | 202.79 | 2.96 | Upgrade
|
| Change in Accounts Receivable | -182.98 | -70.94 | -191.11 | -45.88 | 16.13 | Upgrade
|
| Change in Inventory | 10.82 | 66.19 | -90.38 | -36.29 | -39.09 | Upgrade
|
| Change in Accounts Payable | -82.55 | -352.48 | -4.41 | -264.99 | -472.92 | Upgrade
|
| Change in Other Net Operating Assets | 29.75 | 193.51 | 14.82 | 101.71 | 167.6 | Upgrade
|
| Operating Cash Flow | 442.05 | 449.58 | 94.55 | 35.8 | 206.21 | Upgrade
|
| Operating Cash Flow Growth | -1.68% | 375.51% | 164.08% | -82.64% | -73.02% | Upgrade
|
| Capital Expenditures | -440.65 | -391.01 | -700.17 | -702.94 | -601.72 | Upgrade
|
| Sale of Property, Plant & Equipment | 31.42 | 4.29 | 0.36 | 0.33 | 1.79 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -38.95 | Upgrade
|
| Divestitures | - | - | - | 180.16 | 303.21 | Upgrade
|
| Investment in Securities | 10.82 | 0.34 | 159.62 | 781.92 | -271.33 | Upgrade
|
| Other Investing Activities | 96.81 | 3.19 | 0.3 | 22.5 | 47.82 | Upgrade
|
| Investing Cash Flow | -301.61 | -383.19 | -539.88 | 281.97 | -559.19 | Upgrade
|
| Long-Term Debt Issued | 1,400 | 898.36 | 2,000 | 932.21 | 1,040 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -2.26 | -1.39 | Upgrade
|
| Long-Term Debt Repaid | -1,309 | -1,206 | -1,153 | -816.65 | -1,019 | Upgrade
|
| Total Debt Repaid | -1,309 | -1,206 | -1,153 | -818.91 | -1,020 | Upgrade
|
| Net Debt Issued (Repaid) | 90.38 | -307.16 | 847.22 | 113.3 | 20.06 | Upgrade
|
| Issuance of Common Stock | 80.94 | 793.64 | - | 23.76 | 5.64 | Upgrade
|
| Repurchase of Common Stock | - | -8.16 | -6.37 | -2.47 | -0.96 | Upgrade
|
| Common Dividends Paid | -422.04 | -42.57 | -247.49 | -426.21 | -130.75 | Upgrade
|
| Other Financing Activities | 0.05 | -107.68 | 30.87 | 104.38 | 20.99 | Upgrade
|
| Financing Cash Flow | -250.68 | 328.07 | 624.23 | -187.23 | -85.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.87 | -1.54 | 16.94 | -6.77 | -1.79 | Upgrade
|
| Net Cash Flow | -105.37 | 392.92 | 195.84 | 123.77 | -439.78 | Upgrade
|
| Free Cash Flow | 1.39 | 58.57 | -605.62 | -667.14 | -395.51 | Upgrade
|
| Free Cash Flow Growth | -97.63% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 0.04% | 1.75% | -20.09% | -24.06% | -11.88% | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.05 | -0.57 | -0.62 | -0.37 | Upgrade
|
| Cash Income Tax Paid | 414.04 | 329.11 | 197.09 | 173.38 | 372.96 | Upgrade
|
| Levered Free Cash Flow | -209.72 | -152.29 | -781.91 | -895.41 | -889.24 | Upgrade
|
| Unlevered Free Cash Flow | -186.08 | -125.87 | -750.09 | -878.44 | -872.18 | Upgrade
|
| Change in Net Working Capital | 187.68 | 172.58 | 335.27 | 355.96 | 529.42 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.